Source-grounded facts extracted from SYNOPSYS INC's SEC 8-K filings across all families, newest first. Each cites a verbatim SEC excerpt.
SYNOPSYS INC entered into Cooperation Agreement with Elliott Investment Management L.P., Elliott Associates, L.P. and Elliott International, L.P. (effective 2026-05-26).
“On May 26, 2026, Synopsys, Inc. (“ Synopsys ”) entered into a Cooperation Agreement (the “ Agreement ”) with Elliott Investment Management L.P., Elliott Associates, L.P. and Elliott International, L.P. (collectively, “ Elliott ”).”
Jesse Cohn was appointed as Director at SYNOPSYS INC.
“There are no arrangements or understandings between Mr. Cohn and any other person pursuant to which Mr. Cohn was appointed as a director”
SYNOPSYS INC reported second quarter of fiscal year 2026 results: revenue $2.276 billion, net income $17.1 million, EPS $0.09 per diluted share. Guidance raised.
“Synopsys Posts Financial Results for Second Quarter Fiscal Year 2026 Announces Plan for September 2026 Investor Day Results Summary • Quarterly revenue of $2.276 billion, above prior guidance; quarterly GAAP earnings per diluted share (EPS) of $0.09, and non-GAAP EPS of $3.35”
SYNOPSYS INC issued 4,821,717 shares of common stock to NVIDIA Corporation for $2 billion in cash.
“On December 1, 2025, Synopsys, Inc. (“ Synopsys ”) entered into a Securities Purchase Agreement (the “ Purchase Agreement ”) with NVIDIA Corporation (“ NVIDIA ”). Pursuant to the Purchase Agreement, NVIDIA purchased 4,821,717 shares of Synopsys’ common stock, par value $0.01 per share (the “ Shares ”), at a price per share of $414.79, for an aggregate purchase price of $2 billion in cash.”
SYNOPSYS INC announced a restructuring with charges of $300 million to $350 million (approximately 10% of Synopsys' workforce).
“following the completion of its acquisition of ANSYS, Inc. Synopsys currently estimates that it will recognize pre-tax charges to its GAAP financial results ranging from $300 million to $350 million consisting of severance and other one-time termination benefits, and other costs such as certain site closures as part of its global site strategy. Synopsys”
SYNOPSYS INC incurred term loan of $4.3 billion.
“On July 17, 2025, Synopsys borrowed the full $4.3 billion available under the Term Loan Credit Agreement to fund a portion of the Cash Consideration, to pay transaction fees and expenses related to the Merger, such as the incurrence of indebtedness by Synopsys or one of its subsidiaries, the use of proceeds as described in the Term Loan Credit Agreement and the payment of related fees, premiums and expenses, and to repay Ansys’ outstanding indebtedness.”
SYNOPSYS INC completed an acquisition involving ANSYS, Inc. (closed 2025-07-17).
“On July 17, 2025, Synopsys completed its acquisition of Ansys pursuant to the Merger Agreement.”
SYNOPSYS INC: Changed fiscal year from a 52/53-week period ending on the Saturday nearest October 31 to a calendar-month period ending October 31, effective fiscal year 2025 (effective 2024-11-25).
“Synopsys’ Board of Directors approved changing Synopsys’ fiscal year from a 52/53-week period ending on the Saturday nearest to October 31 of each year to October 31 of each year.”
SYNOPSYS INC: Amended bylaws to change appointment of lead independent director from full Board to independent directors (effective 2024-03-25).
“The Bylaws were updated to provide for the appointment of the lead independent director of the Board (the “ Lead Independent Director ”) by the independent directors of the Board, rather than the full Board, to serve until replaced by the independent directors of the Board, rather than the full Board.”
SYNOPSYS INC reported first quarter of fiscal year 2024 results: revenue $1.649 billion, net income $449.1 million, or $2.89 per diluted share. Guidance raised.
“Synopsys, Inc. (Nasdaq: SNPS ) today reported results for its first quarter of fiscal year 2024. Revenue for the first quarter of fiscal year 2024 was $1.649 billion”
SYNOPSYS INC incurred term loan of up to $4.3 billion with JPMorgan Chase Bank, N.A. (as administrative agent) and the lenders party thereto at Adjusted Term SOFR Rate plus an applicable margin based on the credit ratings of maturing Tranche 1 matures two years after funding; Tranche 2 matures three years after funding.
“On February 13, 2024, Synopsys entered into a Term Loan Facility Credit Agreement (the “Term Loan Agreement”) in connection with the financing of the pending Ansys Merger, by and among Synopsys, the lenders party thereto and JPMorgan Chase Bank, N.A., as administrative agent. The Term Loan Agreement provides us with the ability to borrow up to $4.3 billion at the closing of the Ansys Merger, subject to satisfaction of customary closing conditions for similar facilities, for the purpose of financing a portion of the cash consideration to be paid in the Ansys Merger and paying related fees and expenses in connection with the Ansys Merger and the other transactions contemplated by the Merger Agreement.”
SYNOPSYS INC entered into Term Loan Facility Credit Agreement with JPMorgan Chase Bank, N.A., as administrative agent valued at $4.3 billion (effective 2024-02-13).
“On February 13, 2024, Synopsys entered into a Term Loan Facility Credit Agreement (the “Term Loan Agreement”) in connection with the financing of the pending Ansys Merger, by and among Synopsys, the lenders party thereto and JPMorgan Chase Bank, N.A., as administrative agent.”
SYNOPSYS INC amended Sixth Amendment to Revolving Credit Agreement with JPMorgan Chase Bank, N.A., as administrative agent (effective 2024-02-13).
“On February 13, 2024, Synopsys, Inc. (“Synopsys”) entered into a Sixth Amendment Agreement (the “Sixth Amendment”), by and among Synopsys, the lenders party thereto and JPMorgan Chase Bank, N.A., as administrative agent, which amends and restates Synopsys’ previous credit agreement, dated as of December 14, 2022 (as amended and restated by the Sixth Amendment, the “Revolving Credit Agreement”).”
SYNOPSYS INC entered into Agreement and Plan of Merger with ANSYS, Inc. (effective 2024-01-15).
“On January 15, 2024, Synopsys, Inc. (“ Synopsys ”), entered into an Agreement and Plan of Merger (the “ Merger Agreement ”) by and among Synopsys, ANSYS, Inc., a Delaware corporation (“ Ansys ”), and ALTA Acquisition Corp., a Delaware corporation and wholly owned subsidiary of Synopsys (“ Merger Sub ”).”
Aart J. de Geus was appointed as Executive Chairperson at SYNOPSYS INC.
“and appointed Dr. de Geus to the role of Executive Chairperson of the Board”
Sassine Ghazi changed role as President and Chief Executive Officer at SYNOPSYS INC.
“the Board promoted Mr. Ghazi, Synopsys’ President and Chief Operating Officer, to the role of President and Chief Executive Officer”
SYNOPSYS INC: Amended and restated Bylaws to lower special meeting request threshold from 20% to 15%, clarify director nomination procedures, adopt universal proxy rules, and reflect DGCL changes (effective 2023-12-12).
“on December 12, 2023, Synopsys’ Board of Directors”
SYNOPSYS INC reported fiscal year 2023 results: revenue Record fiscal-year revenue of $5.843 billion, up approximately 15% year over year., net income GAAP net income for fiscal year 2023 was $1.230 billion, or $7.92 per diluted share, EPS Fiscal year GAAP earnings per diluted share of $7.92; non-GAAP earnings per diluted share of $11.19.
“Record fiscal-year revenue of $5.843 billion, up approximately 15% year over year.”
SYNOPSYS INC reported fourth quarter of fiscal year 2023 results: revenue record quarterly revenue of $1.599 billion, up approximately 25% year over year, net income GAAP net income for the fourth quarter of fiscal year 2023 was $349.2 million, or $2.26 per diluted share, EPS quarterly GAAP earnings per diluted share of $2.26; non-GAAP earnings per diluted share of $3.17.
“Synopsys Posts Financial Results for Fourth Quarter and Fiscal Year 2023 Results Summary • Record quarterly revenue of $1.599 billion, up approximately 25% year over year.”
Sassine Ghazi was appointed as Director at SYNOPSYS INC.
“On August 13, 2023, the Board also approved an increase in the size of the Board from ten to eleven directors, and appointed Mr. Ghazi as a director, in each case, effective as of August 13, 2023.”
Sassine Ghazi changed role as President and Chief Executive Officer at SYNOPSYS INC.
“the Board promoted Sassine Ghazi, Synopsys’ President and Chief Operating Officer, to the role of President and Chief Executive Officer”
Aart J. de Geus changed role as Executive Chair of the Board at SYNOPSYS INC.
“On August 12, 2023, Aart J. de Geus informed the Board of Directors (the “ Board ”) of Synopsys, Inc. (“ Synopsys ”) of his intent to step down as Chief Executive Officer of Synopsys, effective January 1, 2024 (the “ Effective Date ”). In connection therewith, on August 13, 2023, the Board promoted Sassine Ghazi, Synopsys’ President and Chief Operating Officer, to the role of President and Chief Executive Officer, and appointed Dr. de Geus to the role of Executive Chair of the Board, in each case, effective as of the Effective Date.”
SYNOPSYS INC reported third quarter of fiscal year 2023 ended July 31, 2023 results: revenue $1.487 billion, net income $336.3 million, or $2.17 per diluted share, EPS $2.17 per diluted share. Guidance raised.
“Results for Third Quarter Fiscal Year 2023 Announces Sassine Ghazi to Assume President and CEO Role Effective Jan. 1, 2024 Q3 FY 2023 Summary • Record quarterly revenue of $1.487 billion, up 19% year over year. • GAAP earnings per diluted share of $2.17; non-GAAP earnings per diluted share of $2.88, exceeded high end of guidance. • Raising full-year 2023 revenue,”
SYNOPSYS INC reported second quarter of fiscal year 2023 results: revenue $1.395 billion, net income net income for the second quarter of fiscal year 2023 was $272.9 million, EPS $1.76 per diluted share. Guidance raised.
“Jim Brady Synopsys, Inc. 408-482-4719 jim.brady@synopsys.com Synopsys Posts Financial Results for Second Quarter Fiscal Year 2023 Q2 FY 2023 Financial Highlights • Revenue: $1.395 billion • GAAP earnings per diluted share: $1.76 • Non-GAAP earnings per diluted share: $2.54 MOUNTAIN VIEW, Calif. – May 17, 2023 – Synopsys, Inc. (Nasdaq: SNPS ) today reported results”
SYNOPSYS INC reported Q1 FY23 results: net income $406.7 million, EPS $2.62.
“Synopsys Posts Financial Results for First Quarter Fiscal Year 2023 Q1 FY 2023 Financial Highlights • Revenue: $1.361 billion • GAAP earnings per diluted share: $1.75 • Non-GAAP earnings per diluted share: $2.62”
SYNOPSYS INC amended revolving credit of upsizes the existing senior unsecured revolving credit facility from $650 million to $850 million maturing December 14, 2027.
“The Fifth Amendment upsizes the existing senior unsecured revolving credit facility from $650 million to $850 million and extends the maturity date of such revolving credit facility from January 22, 2024 to December 14, 2027”
SYNOPSYS INC amended Fifth Extension and Amendment Agreement valued at $850 million (effective 2022-12-14).
“On December 14, 2022, Synopsys, Inc. (“ Synopsys ”) entered into a Fifth Extension and Amendment Agreement (the “ Fifth Amendment ”), which amends and restates Synopsys’ previous credit agreement, dated as of January 22, 2021 (as amended and restated, the “ Credit Agreement ”).”
SYNOPSYS INC reported FY2023 results: revenue 14-15% revenue growth, EPS approximately 16% non-GAAP earnings per share growth. Guidance initiated.
“For fiscal year 2023, we are targeting 14-15% revenue growth, continued non-GAAP operating margin expansion, and approximately 16% non-GAAP earnings per share growth.”
SYNOPSYS INC reported FY2022 Non-GAAP results: net income $1.393 billion, EPS $8.90.
“Non-GAAP net income for fiscal year 2022 was $1.393 billion, or $8.90 per diluted share, compared to non-GAAP net income of $1.077 billion, or $6.84 per diluted share, for fiscal year 2021.”
SYNOPSYS INC reported FY2022 GAAP results: net income $984.6 million, EPS $6.29.
“GAAP net income for fiscal year 2022 was $984.6 million, or $6.29 per diluted share, compared to $757.5 million, or $4.81 per diluted share, for fiscal year 2021.”
SYNOPSYS INC reported FY2022 results: revenue $5.082 billion.
“Revenue for fiscal year 2022 was $5.082 billion, an increase of 20.9 percent from $4.204 billion in fiscal year 2021.”
SYNOPSYS INC reported Q4 FY2022 Non-GAAP results: net income $297.7 million, EPS $1.91.
“On a non-GAAP basis, net income for the fourth quarter of fiscal year 2022 was $297.7 million, or $1.91 per diluted share, compared to non-GAAP net income of $285.8 million, or $1.82 per diluted share, for the fourth quarter of fiscal year 2021.”
SYNOPSYS INC reported Q4 FY2022 GAAP results: net income $153.5 million, EPS $0.99.
“On a generally accepted accounting principles (GAAP) basis, net income for the fourth quarter of fiscal year 2022 was $153.5 million, or $0.99 per diluted share, compared to $201.4 million, or $1.28 per diluted share, for the fourth quarter of fiscal year 2021.”
SYNOPSYS INC reported Q4 FY2022 results: revenue $1.284 billion.
“Revenue for the fourth quarter of fiscal year 2022 was $1.284 billion, compared to $1.152 billion for the fourth quarter of fiscal year 2021.”
Trac Pham changed role as Chief Financial Officer at SYNOPSYS INC.
“Trac Pham will cease serving as Chief Financial Officer of Synopsys, effective as of the Effective Date, and will continue in an executive advisor role through December 2022 to ensure an orderly transition.”
Shelagh Glaser was appointed as Chief Financial Officer at SYNOPSYS INC.
“On November 28, 2022, the Board of Directors (the “ Board ”) of Synopsys, Inc. (“ Synopsys ”) appointed Shelagh Glaser as Chief Financial Officer of Synopsys, effective as of December 2, 2022”
Marc Casper was appointed as Director at SYNOPSYS INC.
“the Board of Directors (the “ Board ”) of Synopsys, Inc. (“ Synopsys ”) increased the size of the Board from eight to ten directors and appointed Luis Borgen and Marc Casper (each an “ Appointee ” and together, the “ Appointees ”) to serve as directors effective immediately.”
Luis Borgen was appointed as Director at SYNOPSYS INC.
“the Board of Directors (the “ Board ”) of Synopsys, Inc. (“ Synopsys ”) increased the size of the Board from eight to ten directors and appointed Luis Borgen and Marc Casper (each an “ Appointee ” and together, the “ Appointees ”) to serve as directors effective immediately.”
Joseph Logan changed role as Chief Revenue Officer at SYNOPSYS INC.
“On May 13, 2022, Joseph Logan notified Synopsys, Inc. of his decision to transition from his role as Chief Revenue Officer at the conclusion of fiscal year 2022.”
Trac Pham departed as Chief Financial Officer at SYNOPSYS INC.
“On November 28, 2021, Trac Pham notified Synopsys, Inc. (“ Synopsys ”) that he intends to retire as Chief Financial Officer of Synopsys in 2022.”
Chi-Foon Chan departed as co-Chief Executive Officer at SYNOPSYS INC.
“Chi-Foon Chan will transition from his role of President of Synopsys as of November 1, 2021, and will continue as co-Chief Executive Officer until April 30, 2022.”
Chi-Foon Chan changed role as co-Chief Executive Officer at SYNOPSYS INC.
“Chi-Foon Chan will transition from his role of President of Synopsys as of November 1, 2021, and will continue as co-Chief Executive Officer until April 30, 2022.”
Sassine Ghazi was appointed as President and Chief Operating Officer at SYNOPSYS INC.
“On September 13, 2021, the Board of Directors of Synopsys, Inc. (“ Synopsys ”) appointed Sassine Ghazi, currently Chief Operating Officer of Synopsys, as President and Chief Operating Officer of Synopsys, effective as of November 1, 2021.”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.